V. Marc Droppert, Executive Vice President at Omrix Biopharmaceuticals, Inc. (OMRI), bought 4,000 shares at $12.48 ($50K) on 2008-03-18, disclosed to the SEC on 2008-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.